openPR Logo
Press release

OTC Drug Market Report Research : 2017

09-06-2017 11:46 AM CET | Health & Medicine

Press release from: REPORTSANDMARKETS

/ PR Agency: REPORTSANDMARKETS
otc drug market size, otc drug market, otc drug market trends, otc drug market share, otc drug market analysis, the worldwide over

otc drug market size, otc drug market, otc drug market trends, otc drug market share, otc drug market analysis, the worldwide over

Reports And Markets Publish a New Market Research Report On –" OTC Drug Market Report Research : 2017"

Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/asia-pacific-otc-drug-market-report-2017-1541262

In this report, the Asia-Pacific OTC Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of OTC Drug for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific OTC Drug market competition by top manufacturers/players, with OTC Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Bayer HealthCare
GlaxoSmithKline (GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
Class A
Class B

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of OTC Drug for each application, includin
Hospital
Clinic
Household

If you have any special requirements, please let us know and we will offer you the report as you want.

Request For Sample Report @ https://www.reportsandmarkets.com/sample-request/asia-pacific-otc-drug-market-report-2017-1541262

Table of Contents

Asia-Pacific OTC Drug Market Report 2017
1 OTC Drug Overview
1.1 Product Overview and Scope of OTC Drug
1.2 Classification of OTC Drug by Product Category
1.2.1 Asia-Pacific OTC Drug Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific OTC Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Class A
1.2.4 Class B
1.3 Asia-Pacific OTC Drug Market by Application/End Users
1.3.1 Asia-Pacific OTC Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 Asia-Pacific OTC Drug Market by Region
1.4.1 Asia-Pacific OTC Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of OTC Drug (2012-2022)
1.5.1 Asia-Pacific OTC Drug Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific OTC Drug Revenue and Growth Rate (2012-2022)

2 Asia-Pacific OTC Drug Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific OTC Drug Market Competition by Players/Suppliers
2.1.1 Asia-Pacific OTC Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific OTC Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific OTC Drug (Volume and Value) by Type
2.2.1 Asia-Pacific OTC Drug Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific OTC Drug Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific OTC Drug (Volume) by Application
2.4 Asia-Pacific OTC Drug (Volume and Value) by Region
2.4.1 Asia-Pacific OTC Drug Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific OTC Drug Revenue and Market Share by Region (2012-2017)

3 China OTC Drug (Volume, Value and Sales Price)
3.1 China OTC Drug Sales and Value (2012-2017)
3.1.1 China OTC Drug Sales Volume and Growth Rate (2012-2017)
3.1.2 China OTC Drug Revenue and Growth Rate (2012-2017)
3.1.3 China OTC Drug Sales Price Trend (2012-2017)
3.2 China OTC Drug Sales Volume and Market Share by Type
3.3 China OTC Drug Sales Volume and Market Share by Application

4 Japan OTC Drug (Volume, Value and Sales Price)
4.1 Japan OTC Drug Sales and Value (2012-2017)
4.1.1 Japan OTC Drug Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan OTC Drug Revenue and Growth Rate (2012-2017)
4.1.3 Japan OTC Drug Sales Price Trend (2012-2017)
4.2 Japan OTC Drug Sales Volume and Market Share by Type
4.3 Japan OTC Drug Sales Volume and Market Share by Application

5 South Korea OTC Drug (Volume, Value and Sales Price)
5.1 South Korea OTC Drug Sales and Value (2012-2017)
5.1.1 South Korea OTC Drug Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea OTC Drug Revenue and Growth Rate (2012-2017)
5.1.3 South Korea OTC Drug Sales Price Trend (2012-2017)
5.2 South Korea OTC Drug Sales Volume and Market Share by Type
5.3 South Korea OTC Drug Sales Volume and Market Share by Application

6 Taiwan OTC Drug (Volume, Value and Sales Price)
6.1 Taiwan OTC Drug Sales and Value (2012-2017)
6.1.1 Taiwan OTC Drug Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan OTC Drug Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan OTC Drug Sales Price Trend (2012-2017)
6.2 Taiwan OTC Drug Sales Volume and Market Share by Type
6.3 Taiwan OTC Drug Sales Volume and Market Share by Application

7 India OTC Drug (Volume, Value and Sales Price)
7.1 India OTC Drug Sales and Value (2012-2017)
7.1.1 India OTC Drug Sales Volume and Growth Rate (2012-2017)
7.1.2 India OTC Drug Revenue and Growth Rate (2012-2017)
7.1.3 India OTC Drug Sales Price Trend (2012-2017)
7.2 India OTC Drug Sales Volume and Market Share by Type
7.3 India OTC Drug Sales Volume and Market Share by Application

8 Southeast Asia OTC Drug (Volume, Value and Sales Price)
8.1 Southeast Asia OTC Drug Sales and Value (2012-2017)
8.1.1 Southeast Asia OTC Drug Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia OTC Drug Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia OTC Drug Sales Price Trend (2012-2017)
8.2 Southeast Asia OTC Drug Sales Volume and Market Share by Type
8.3 Southeast Asia OTC Drug Sales Volume and Market Share by Application

9 Australia OTC Drug (Volume, Value and Sales Price)
9.1 Australia OTC Drug Sales and Value (2012-2017)
9.1.1 Australia OTC Drug Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia OTC Drug Revenue and Growth Rate (2012-2017)
9.1.3 Australia OTC Drug Sales Price Trend (2012-2017)
9.2 Australia OTC Drug Sales Volume and Market Share by Type
9.3 Australia OTC Drug Sales Volume and Market Share by Application

10 Asia-Pacific OTC Drug Players/Suppliers Profiles and Sales Data
10.1 Bayer HealthCare
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 OTC Drug Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 GlaxoSmithKline (GSK)
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 OTC Drug Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Johnson&Johnson
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 OTC Drug Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Johnson&Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Pfizer
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 OTC Drug Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Sanofi
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 OTC Drug Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 AstraZeneca
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 OTC Drug Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 BioGaia
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 OTC Drug Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Bristol Myers Squibb
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 OTC Drug Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Bukwang Pharmaceutica
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 OTC Drug Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Chr. Hansen
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 OTC Drug Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Cipla
10.12 CoLucid
10.13 Daiichi Sankyo
10.14 Friggs
10.15 DSM
10.16 Eisai
10.17 Eli Lilly
10.18 Herbalife
10.19 Euradite

11 OTC Drug Manufacturing Cost Analysis
11.1 OTC Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of OTC Drug

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 OTC Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific OTC Drug Market Forecast (2017-2022)
15.1 Asia-Pacific OTC Drug Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific OTC Drug Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific OTC Drug Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific OTC Drug Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific OTC Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific OTC Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific OTC Drug Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific OTC Drug Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific OTC Drug Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific OTC Drug Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific OTC Drug Price Forecast by Type (2017-2022)
15.4 Asia-Pacific OTC Drug Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer

Check Discount @ https://www.reportsandmarkets.com/check-discount/asia-pacific-otc-drug-market-report-2017-1541262

For more information or any query mail at sales@reportsandmarkets.com

About Reports And Markets

Reports And Markets is part of the Algoro Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Are you mastering your market? Do you know what the market potential is for your product, who the market players are and what the growth forecast is? We offer standard global, regional or country specific market research studies for almost every market you can imagine.

Contact Person

Sanjay Jain

Manager - Partner Relations & International Marketing

info@reportsandmarkets.com

Ph: +1-214-377-1121 (US), +44-020-3286-9338 (UK)

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OTC Drug Market Report Research : 2017 here

News-ID: 700229 • Views: 264

More Releases from REPORTSANDMARKETS

Global Litigation Funding as Corporate Finance Market Detailed Insight Into The …
Global Litigation Funding as Corporate Finance Market Size, Status and Forecast 2019-2025 The Global Litigation Funding as Corporate Finance 2018 Market Research Report is a professional and in-depth study on the current state of Litigation Funding as Corporate Finance Market. The report provides a basic overview of the industry including definitions and classifications. The Litigation Funding as Corporate Finance analysis is provided for the international markets including development trends, competitive landscape analysis,
Global Digital Transformation in Customer Experience Market, Top key players are …
Global Digital Transformation in Customer Experience Market Report 2019 2019 Digital Transformation in Customer Experience Market Report is a professional and in-depth research report on the world's major regional market conditions of the Digital Transformation in Customer Experience Market industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Digital Transformation in Customer Experience Market basics:
Global Digital transformation In Event Management market, Top key players are La …
Global Digital transformation In Event Management market industry 2019 The Global Digital transformation In Event Management market industry 2019 Market Research Report is a professional and in-depth study on the current state of the Global Digital transformation In Event Management market industry. The report provides a basic overview of the industry including definitions and classifications. The Global Digital transformation In Event Management market analysis is provided for the international markets including development
Global Digital Transformation in 5G Wireless Technology Market, Top key players …
Global Digital Transformation in 5G Wireless Technology Market Report 2019 2019 Digital Transformation in 5G Wireless Technology Market Report is a professional and in-depth research report on the world's major regional market conditions of the Digital Transformation in 5G Wireless Technology Market industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Digital Transformation in

All 5 Releases


More Releases for OTC

Foods Matrix Inc. Exploring OTC Markets Listing
Foods Matrix Inc. (FMI), a US based food processing startup is exploring options to list on the OTC Markets. FMI is in talks to acquire a distressed food processing unit in the state of Punjab, India for US $3 million. The deal may be sealed by the end of November, 2018, post completion of the ongoing due diligence. FMI may initially quote on the pink sheet segment of the OTC Markets
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
11-28-2017 | Health & Medicine
Fact.MR
7 Key Projections for OTC Analgesics Market
The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Request For Sample Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years. Various off-label drugs including tricyclic antidepressants, antihistamines,
Clariant acquires Oberhausen Technology Center (OTC)
 Acquisition is part of company strategy to develop and strengthen ICS portfolio  Clariant gains technological expertise in new formulation technologies and delivery systems to serve customer needs in the consumer care market Muttenz, October 26, 2011 – The Swiss specialty chemicals group Clariant has acquired German company Oberhausen Technology Center (OTC) to further strengthen its Industrial & Consumer Specialties Business Unit (ICS). Financial details of the acquisition are not being disclosed. The
OTC Perspectives Announces 2010 Ad Awards Finalists
FLORHAM PARK, N.J. [March 22, 2010] – OTC Perspectives, Inc., the leading conference, training and publishing company for over-the-counter (OTC) marketing, today announced the finalists for the 2nd annual OTC National Advertising Awards, presented in conjunction with the OTC National Conference, May 18-19, in Philadelphia, PA. The award winners will be announced at the OTC National Advertising Awards reception, sponsored by HealthCentral, on the night of May l8,
CybeRelease: (OTC: BDMHF) Gets Spanish Distribution Agreement
( CybeRelease, August 7, 2007 ) - Lake Harmony, Pa. - Black Diamond Brands, Corp. (OTC BB: BDMHF) announced its wholly owned subsidiary, Black Diamond Importers Inc., has been appointed importing agents for Bodega De Sarria in British Columbia, Canada. Bodega De Sarria is set within the estate of the Senorio de Sarria (Manor of the Sarria Family) on the outskirts of the town of Puente la Reina, Spain. Its